APPARATUS FOR DELIVERY OF PHARMACEUTICALS TO THE COCHLEA
First Claim
Patent Images
1. A cochlear implant electrode assembly device comprising:
- a resiliently flexible elongate member having disposed therein a sealable reservoir configured to receive a bio-active substance;
a plurality of electrodes mounted on said elongate member configured to provide stimulation to a cochlea; and
a substance egress fluidically coupling said reservoir to the exterior of said elongate member, wherein said substance egress is configured to release said bio-active substance from said reservoir following implantation of said device, wherein said substance egress comprises an opening in said reservoir, wherein at least said substance egress is sealed with a layer of bioresorable material configured to dissolve following implantation of said device,wherein said elongate member further comprises a coating of lubricious material on at least a portion of the outer surface of said elongate member.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable tissue-stimulating device, such as a cochlear implant, having a resiliently flexible elongate member (11) having a plurality of electrodes (12) positioned thereon. The elongate member (11) provides a means of delivering at least one bio-active substance to the implantee following implantation of the elongate member (11). The delivery means can comprise a lumen 21 containing the bio-active substance in a liquid form. The bio-active substance can comprise a steroid or can perform a function of reducing the resting neuron potential of neurons within the cochlea.
-
Citations
3 Claims
-
1. A cochlear implant electrode assembly device comprising:
-
a resiliently flexible elongate member having disposed therein a sealable reservoir configured to receive a bio-active substance; a plurality of electrodes mounted on said elongate member configured to provide stimulation to a cochlea; and a substance egress fluidically coupling said reservoir to the exterior of said elongate member, wherein said substance egress is configured to release said bio-active substance from said reservoir following implantation of said device, wherein said substance egress comprises an opening in said reservoir, wherein at least said substance egress is sealed with a layer of bioresorable material configured to dissolve following implantation of said device, wherein said elongate member further comprises a coating of lubricious material on at least a portion of the outer surface of said elongate member. - View Dependent Claims (2, 3)
-
Specification